AstraZeneca holds a unique position in respiratory disease, including asthma and chronic obstructive pulmonary disease (COPD), with a range of differentiated potential medicines in development.
Base: $147,535.20 - $224,302.80; Bonus/Equity: eligibility for various incentives, short-term incentive bonuses, equity-based awards; Benefits: qualified retirement programs, paid time off, health, dental, and vision coverage
Must-have
Nice-to-have
Not specified